Catalyst
Slingshot members are tracking this event:
Aurinia (AUPH) Expects Data Readout in 2016 of Phase 2b AURA-LV Study of Voclosporin in Active Lupus Nephritis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AUPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 15, 2016
Occurred Source:
http://www.auriniapharma.com/dnn/LinkClick.aspx?fileticket=ifNeeSftXPk%3d&tabid=92&mid=738
Related Projects
- A Discussion on Aurinia's AURION Preliminary Analysis of Voclosporin in Active Lupus Nephritis (LN) Ahead of 2016 Readout of Phase 2b AURA-LV Data AUPH Executed On: Jun 30, 2016 at 09:00 AM EDT
Related Keywords
Data Readout, 2016, Phase 2b Study, Aura-lv, Voclosporin, Active Lupus Nephritis
